Anxiety disorders in patients with Parkinson's disease
To study the prevalence and importance of anxiety disorders in patients with idiopathic Parkinson's disease, the authors systematically evaluated 24 parkinsonian patients for the presence of DSM-III-R axis I syndromes. Nine subjects (38%) had a clinically significant current anxiety disorder. S...
Gespeichert in:
| Veröffentlicht in: | The American journal of psychiatry 1990-02, Vol.147 (2), p.217-220 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 220 |
|---|---|
| container_issue | 2 |
| container_start_page | 217 |
| container_title | The American journal of psychiatry |
| container_volume | 147 |
| creator | STEIN, M. B HEUSER, I. J JUNCOS, J. L UHDE, T. W |
| description | To study the prevalence and importance of anxiety disorders in patients
with idiopathic Parkinson's disease, the authors systematically evaluated
24 parkinsonian patients for the presence of DSM-III-R axis I syndromes.
Nine subjects (38%) had a clinically significant current anxiety disorder.
Severity of anxiety was not correlated with severity of parkinsonian
symptoms, cumulative duration of L-dopa exposure, or current dose of
L-dopa. These findings suggest that anxiety disorders should be considered
in the medical evaluation and treatment of parkinsonian patients and that
further attention should be paid to the role of the dopaminergic system in
anxiety and phobic disorders. |
| doi_str_mv | 10.1176/ajp.147.2.217 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_220471082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1310618817</sourcerecordid><originalsourceid>FETCH-LOGICAL-a407t-14c69c7a5aac529006baced6cb79c863126ad5ffd6038a93e880e44accfe50b53</originalsourceid><addsrcrecordid>eNp10EtLw0AQB_BFlFofR49CUEEQEveRfeRYii8o6EHB2zLZbHBrm8TdFO23d2tL8aCnYZgfM8MfoROCM0KkuIZpl5FcZjSjRO6gIeGMp5JStYuGGGOaFpy97qODEKaxxUzSARpQhokQ-RCJUfPlbL9MKhdaX1kfEtckHfTONn1IPl3_ljyBf3dNaJvLsGIWgj1CezXMgj3e1EP0cnvzPL5PJ493D-PRJIUcyz4luRGFkcABDKcFxqIEYythSlkYJRihAipe15XATEHBrFLY5jkYU1uOS84O0dl6b-fbj4UNvZ62C9_Ek5pSnEuCFY3o_D9EGMGCKEVkVOlaGd-G4G2tO-_m4JeaYL1KUsckdUxSU01__Olm66Kc22qrN9HF-cVmDsHArPbQGBe2TChBKBeRXa0ZdJ379difN78BxOaHpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310618817</pqid></control><display><type>article</type><title>Anxiety disorders in patients with Parkinson's disease</title><source>MEDLINE</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>STEIN, M. B ; HEUSER, I. J ; JUNCOS, J. L ; UHDE, T. W</creator><creatorcontrib>STEIN, M. B ; HEUSER, I. J ; JUNCOS, J. L ; UHDE, T. W</creatorcontrib><description>To study the prevalence and importance of anxiety disorders in patients
with idiopathic Parkinson's disease, the authors systematically evaluated
24 parkinsonian patients for the presence of DSM-III-R axis I syndromes.
Nine subjects (38%) had a clinically significant current anxiety disorder.
Severity of anxiety was not correlated with severity of parkinsonian
symptoms, cumulative duration of L-dopa exposure, or current dose of
L-dopa. These findings suggest that anxiety disorders should be considered
in the medical evaluation and treatment of parkinsonian patients and that
further attention should be paid to the role of the dopaminergic system in
anxiety and phobic disorders.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.147.2.217</identifier><identifier>PMID: 2301664</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Washington, DC: American Psychiatric Publishing</publisher><subject>Adult ; Aged ; Anxiety Disorders - etiology ; Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dopamine - physiology ; Female ; Health care ; Humans ; Levodopa - adverse effects ; Male ; Medical sciences ; Mental disorders ; Middle Aged ; Neurological disorders ; Neurology ; Parkinson Disease - complications ; Parkinson Disease - drug therapy ; Psychiatry</subject><ispartof>The American journal of psychiatry, 1990-02, Vol.147 (2), p.217-220</ispartof><rights>1990 INIST-CNRS</rights><rights>Copyright American Psychiatric Association Feb 1990</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a407t-14c69c7a5aac529006baced6cb79c863126ad5ffd6038a93e880e44accfe50b53</citedby><cites>FETCH-LOGICAL-a407t-14c69c7a5aac529006baced6cb79c863126ad5ffd6038a93e880e44accfe50b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.147.2.217$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.147.2.217$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,780,784,2859,21629,27869,27924,27925,77791,77792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6861256$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2301664$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STEIN, M. B</creatorcontrib><creatorcontrib>HEUSER, I. J</creatorcontrib><creatorcontrib>JUNCOS, J. L</creatorcontrib><creatorcontrib>UHDE, T. W</creatorcontrib><title>Anxiety disorders in patients with Parkinson's disease</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>To study the prevalence and importance of anxiety disorders in patients
with idiopathic Parkinson's disease, the authors systematically evaluated
24 parkinsonian patients for the presence of DSM-III-R axis I syndromes.
Nine subjects (38%) had a clinically significant current anxiety disorder.
Severity of anxiety was not correlated with severity of parkinsonian
symptoms, cumulative duration of L-dopa exposure, or current dose of
L-dopa. These findings suggest that anxiety disorders should be considered
in the medical evaluation and treatment of parkinsonian patients and that
further attention should be paid to the role of the dopaminergic system in
anxiety and phobic disorders.</description><subject>Adult</subject><subject>Aged</subject><subject>Anxiety Disorders - etiology</subject><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dopamine - physiology</subject><subject>Female</subject><subject>Health care</subject><subject>Humans</subject><subject>Levodopa - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental disorders</subject><subject>Middle Aged</subject><subject>Neurological disorders</subject><subject>Neurology</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - drug therapy</subject><subject>Psychiatry</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNp10EtLw0AQB_BFlFofR49CUEEQEveRfeRYii8o6EHB2zLZbHBrm8TdFO23d2tL8aCnYZgfM8MfoROCM0KkuIZpl5FcZjSjRO6gIeGMp5JStYuGGGOaFpy97qODEKaxxUzSARpQhokQ-RCJUfPlbL9MKhdaX1kfEtckHfTONn1IPl3_ljyBf3dNaJvLsGIWgj1CezXMgj3e1EP0cnvzPL5PJ493D-PRJIUcyz4luRGFkcABDKcFxqIEYythSlkYJRihAipe15XATEHBrFLY5jkYU1uOS84O0dl6b-fbj4UNvZ62C9_Ek5pSnEuCFY3o_D9EGMGCKEVkVOlaGd-G4G2tO-_m4JeaYL1KUsckdUxSU01__Olm66Kc22qrN9HF-cVmDsHArPbQGBe2TChBKBeRXa0ZdJ379difN78BxOaHpg</recordid><startdate>19900201</startdate><enddate>19900201</enddate><creator>STEIN, M. B</creator><creator>HEUSER, I. J</creator><creator>JUNCOS, J. L</creator><creator>UHDE, T. W</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>19900201</creationdate><title>Anxiety disorders in patients with Parkinson's disease</title><author>STEIN, M. B ; HEUSER, I. J ; JUNCOS, J. L ; UHDE, T. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a407t-14c69c7a5aac529006baced6cb79c863126ad5ffd6038a93e880e44accfe50b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anxiety Disorders - etiology</topic><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dopamine - physiology</topic><topic>Female</topic><topic>Health care</topic><topic>Humans</topic><topic>Levodopa - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental disorders</topic><topic>Middle Aged</topic><topic>Neurological disorders</topic><topic>Neurology</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - drug therapy</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STEIN, M. B</creatorcontrib><creatorcontrib>HEUSER, I. J</creatorcontrib><creatorcontrib>JUNCOS, J. L</creatorcontrib><creatorcontrib>UHDE, T. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STEIN, M. B</au><au>HEUSER, I. J</au><au>JUNCOS, J. L</au><au>UHDE, T. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anxiety disorders in patients with Parkinson's disease</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>1990-02-01</date><risdate>1990</risdate><volume>147</volume><issue>2</issue><spage>217</spage><epage>220</epage><pages>217-220</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>To study the prevalence and importance of anxiety disorders in patients
with idiopathic Parkinson's disease, the authors systematically evaluated
24 parkinsonian patients for the presence of DSM-III-R axis I syndromes.
Nine subjects (38%) had a clinically significant current anxiety disorder.
Severity of anxiety was not correlated with severity of parkinsonian
symptoms, cumulative duration of L-dopa exposure, or current dose of
L-dopa. These findings suggest that anxiety disorders should be considered
in the medical evaluation and treatment of parkinsonian patients and that
further attention should be paid to the role of the dopaminergic system in
anxiety and phobic disorders.</abstract><cop>Washington, DC</cop><pub>American Psychiatric Publishing</pub><pmid>2301664</pmid><doi>10.1176/ajp.147.2.217</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-953X |
| ispartof | The American journal of psychiatry, 1990-02, Vol.147 (2), p.217-220 |
| issn | 0002-953X 1535-7228 |
| language | eng |
| recordid | cdi_proquest_journals_220471082 |
| source | MEDLINE; Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online |
| subjects | Adult Aged Anxiety Disorders - etiology Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dopamine - physiology Female Health care Humans Levodopa - adverse effects Male Medical sciences Mental disorders Middle Aged Neurological disorders Neurology Parkinson Disease - complications Parkinson Disease - drug therapy Psychiatry |
| title | Anxiety disorders in patients with Parkinson's disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A41%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anxiety%20disorders%20in%20patients%20with%20Parkinson's%20disease&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=STEIN,%20M.%20B&rft.date=1990-02-01&rft.volume=147&rft.issue=2&rft.spage=217&rft.epage=220&rft.pages=217-220&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/ajp.147.2.217&rft_dat=%3Cproquest_cross%3E1310618817%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310618817&rft_id=info:pmid/2301664&rfr_iscdi=true |